期刊文献+

变形链球菌表面蛋白PAc的原核表达及纯化 被引量:6

Prokaryotic Expression and Purification of Streptococcus Mutans Surface Protein(PAc)
暂未订购
导出
摘要 目的:对在大肠杆菌中表达重组变形链球菌表面蛋白抗原PAc的培养条件进行优化,制备高纯度重组蛋白rPAc。方法:载体构建原核表达载体pET20b(+)-AP对不同培养基、诱导浓度,温度和时间等进行筛选确定最佳条件,采用亲和层析分离纯化rPAc蛋白。结果:含原核表达载体pET20b(+)-AP的大肠杆菌在LB培养基中培养至A600=0.6时,终浓度为1mM的IPTG诱导,30℃继续振荡培养4h,可使rPAc的表达量达到最大。分离纯化的蛋白在SDS-PAGE中显示为单一条带。结论:对PAcA-P区的重组质粒pET20b(+)-AP表达的rPAc经纯化后可用于动物免疫,为探索防龋DNA疫苗pCIA-P的新型免疫策略奠定必要的物质基础。 Objective: To express and purify the surface protein antigen(PAc) of streptococcus mutans in E. coli BL21(DE3) plysS and optimize the cultivation reguIation. Methods: The recombinant plasmid pET20b(+ )- AP was expressed in E. coli BL21(DE3)plysS and the expression level of rPAc was detected by SDS--PAGE under dif- ferent cultivation conditions, including concentration of IPTG, growth rate of bacterial, and etc. After that, the expressed recombinant protein rPAc was.purified using immobilized metal ion affinity chromatography and identified by SDS--PAGE. Results: It was found that the expression level of rPAc achieved the highest when the BL21(DE3) plysS had been induced for 4h with 1mM IPTG beginning from strain density of A600=0.6 at 30℃. rPAc was puri- fied from the soluble phase by means of His--tag affinity chromatography on a nickel--charged column, with a yield of approximately 300 mg of protein per liter of culture. Conclusion: The recombinant protein has antigenicity and can be acted as candidate anti--caries vaccine. This study could lay a material foundation for the further research of DNA prime--protein boost inoculation.
出处 《口腔医学研究》 CAS CSCD 北大核心 2010年第1期60-63,共4页 Journal of Oral Science Research
基金 国家自然科学基金资助项目(编号:30600707)
关键词 变形链球菌表面蛋白PAc 重组蛋白 初免-加强免疫DNA疫苗 Streptococcus mutans surface protein DNA prime--protein boost Recombinant protein DNA vaccine
  • 相关文献

参考文献11

  • 1Koga T, Okahashi N,T akahashi I, et al. Surface hydrophobicity, adherence, and aggregation of cell surface protein antigen mutants of Streptococcus mutans serotype c [J]. Infect Immun, 1990, 58 : 989-296.
  • 2Gibbons RJ, Etherden I. Comparative hydrophobicities of oral bacteria and their adherence to salivary pellicles [J] Infect Immun, 1983, 41 : 1190 -1197.
  • 3Okahashi N, Koga T, Hanada S. Purification and immunochemical properties of protein antigen from serotype g Streptococcus mutans [J]. Mierobiol Immunol, 1986, 30(1) : 35-37.
  • 4Takahashi I, Okahashi N, Sasakawa C, et al. Homology between surface protein antigen genes of Streptococcus sobrlnus and Streptococcus mutans [J]. FEBS Lett, 1989, 249 : 383 - 390.
  • 5李宇红,樊明文,边专,陈智,郭继华.靶向融合防龋DNA疫苗免疫田鼠的实验研究[J].口腔医学研究,2004,20(5):450-453. 被引量:4
  • 6Ram say AJ, Kent SJ, Strugnell RA, et al. Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity[J]. Immunol Rev, 1999, 171 : 27- 44.
  • 7张睿,樊明文,彭彬,李宇红.DNA防龋疫苗联合蛋白质疫苗诱导小鼠免疫应答的研究[J].口腔医学研究,2008,24(3):245-247. 被引量:9
  • 8Li Y, Jin J, Yang Y, et al. Enhamced immunogenicity of an anti canies vaccine encoding a cell--surface protein antigen of streptococcus mutans by intranasal DNA prime--proeein boost immunization [J]. J Gene Med, 2009,11(11) : 1039-1047.
  • 9Donovan RS, Robinson CW, Glick BR. Review: Optimizing Inducer and Culture Conditions for Expression of Foreign Protein under the Control of the Lac Promoter [J]. Ind Microbiol, 1996, 16 : 145- 154.
  • 10Donovan RS, Robinson CW, Glick BR. Optimizing the Expressionof a Monoclonal Antibody Fragment under the Transcriptional Control of the Escherichia coil Lac Promoter [J]. Can J Microbiol, 2000, 46(6): 532- 541.

二级参考文献20

  • 1杜宇,樊明文,李宇红,郭继华,边专,陈智.防龋DNA疫苗pGJA-P/VAX免疫小鼠后的抗DNA抗体检测[J].口腔医学研究,2006,22(5):465-467. 被引量:9
  • 2张若寒.植酸酶活性的检测方法[J].中国饲料,1997(5):30-32. 被引量:53
  • 3Fan MW, Bian Z, Peng ZX, et al. A DNA Vaccine Encoding a Cell- surface Protein Antigen of Streptococcus mutans Protects Gnotobiotic Rats from Caries [J]. J Dent Res, 2002, 81:784- 787
  • 4Ramshao IA, Ramasay AJ. The prime -boost strategy: exiting prospect for improved vaccination [ J]. Immunol Today, 2000, 21 (4): 163 - 165
  • 5Kaul D, Ogra PL. Mucosal responses to parenteral and mucosal vaccine [J]. Dev Bio Stand, 1995, 141 - 146
  • 6Mancini - Bourgine M, Fontaine H, Scott - Algara D, et al. Induction or expansion of T - cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers [J]. Hepatology, 2004, 40:874 -882
  • 7Scheerlinck JP, Casey G,M cW aters P, et al. The immune response to a DNA vaccine can be modulated by co delivery ofcytok ine genes using a DNA prime protein boost strategy [ J]. Vaccine, 2001, 19 (28 -29) :4053 -4060
  • 8Susan WB, Sabita R, Harold L, et al. Vaccination with HIV - 1 gpl20 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit [J]. Vaccine, 1997, 15:869 -873
  • 9Kanellos TS, Byarugaba DK, Russell PH, et al. Naked DNA when co - administered intranally with heat - labile Enterotoxin of Escherichia coli Primes effectively for systemic B - and T - cell responses to the encoded antigen [J]. Immun lett, 2000, 74: 215 -220
  • 10Masanori Isaka, Takako Komiya, Motohide Takahashi, et al. Recombinant cholera toxin B subunit (rCTB) as a mueosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria -pertussis - tetanus (DPT) combination vaccine [J]. Vaccine, 2004, 22:3061 - 3068

共引文献15

同被引文献38

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部